16 Nov, 2022 Press Releases Curevo Vaccine Announces $26 Million Series A1 Financing to Support Clinical Development of Next-Generation Subunit Vaccines by curevovaccine
15 Sep, 2022 Press Releases Curevo Vaccine Announces Enrollment Complete in Phase 2b Trial of CRV-101 Vaccine Against Shingles by curevovaccine 4 Comments
10 Feb, 2022 News, Press Releases, Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines by curevovaccine
28 Sep, 2021 Events, Vaccines Curevo Presenting at World Vaccine Conference Congress (Washington) Sept 28 – Oct 1 by curevovaccine
